Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 5, 2010, Pages 547-551

  Staekenborg, Salka S ^a   Su, Tanja ^a   Van Straaten, Elisabeth C W ^a   Lane, Roger ^b   Scheltens, Philip ^a   Barkhof, Frederik ^a   Van Der Flier, Wiesje M ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NOVARTIS PHARMA AG   (Switzerland)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL BENZOATE PLUS PROGESTERONE; CARBAMIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT; RIVASTIGMINE;

AGED; AGGRESSION; AGITATION; APATHY; ARTICLE; BEHAVIOR DISORDER; CAPILLARY; CLINICAL FEATURE; DEPRESSION; DISEASE SEVERITY; EUPHORIA; FEMALE; GREAT BLOOD VESSEL; HALLUCINATION; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; VASCULAR DISEASE; BRAIN CIRCULATION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; IMAGE PROCESSING; MULTICENTER STUDY; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS;

AGED; CAPILLARIES; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; COHORT STUDIES; DEMENTIA, VASCULAR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEUROPROTECTIVE AGENTS; PHENYLCARBAMATES; SOCIOECONOMIC FACTORS;

EID: 77952571586     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.187500     Document Type: Article

References (26)

1. Finkel SI. Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers. J Clin Psychiatry 2001;62(Suppl 21): 3-6.
2. Frisoni GB, Rozzini L, Gozzetti A, et al. Behavioral syndromes in Alzheimer's disease: description and correlates. Dement Geriatr Cogn Disord 1999;10:130-8.
3. Mega MS, Cummings JL, Fiorello T, et al. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996;46:1300-5. (Pubitemid 26156117)
4. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
5. Caputo M, Monastero R, Mariani E, et al. Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types. Acta Psychiatr Scand 2008;117:455-64.
6. Fuh JL, Wang SJ, Cummings JL. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J Neurol Neurosurg Psychiatry 2005;76:1337-41.
7. Hsieh CJ, Chang CC, Lin CC. Neuropsychiatric profiles of patients with Alzheimer's disease and vascular dementia in Taiwan. Int J Geriatr Psychiatry 2009;24:570-7.
8. Lyketsos CG, Steinberg M, Tschanz JT, et al. Mental and behavioral disturbances in dementia: findings from the Cache County Study on memory in aging. Am J Psychiatry 2000;157:708-14.
9. Moretti R, Torre P, Antonello RM, et al. Behavioral alterations and vascular dementia. Neurologist 2006;12:43-7.
10. Srikanth S, Nagaraja AV, Ratnavalli E. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. J Neurol Sci 2005;236:43-8.
11. Angelelli P, Paolucci S, Bivona U, et al. Development of neuropsychiatric symptoms in poststroke patients: a cross-sectional study. Acta Psychiatr Scand 2004;110:55-63.
12. van Straaten EC, Scheltens P, Knol DL, et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke 2003;34:1907-12.
13. Ballard C, Sauter M, Scheltens P, et al. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Curr Med Res Opin 2008;24:2561-74.
14. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-14. (Pubitemid 24382728)
15. Aharon-Peretz J, Kliot D, Tomer R. Behavioral differences between white matter lacunar dementia and Alzheimer's disease: a comparison on the neuropsychiatric inventory. Dement Geriatr Cogn Disord 2000;11:294-8. (Pubitemid 30665932)
16. Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006;16:916-28.
17. Reyes S, Viswanathan A, Godin O, et al. Apathy: a major symptom in CADASIL. Neurology 2009;72:905-10.
18. Aarsland D, Litvan I, Larsen JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001;13:42-9.
19. Bruen PD, McGeown WJ, Shanks MF, et al. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain 2008;131:2455-63.
20. Pluck GC, Brown RG. Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:636-42.
21. Gold G, Giannakopoulos P, Montes-Paixao JC, et al. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997;49:690-4.
22. Botez SA, Carrera E, Maeder P, et al. Aggressive behavior and posterior cerebral artery stroke. Arch Neurol 2007;64:1029-33.
23. Kim JS, Choi S, Kwon SU, et al. Inability to control anger or aggression after stroke. Neurology 2002;58:1106-8. (Pubitemid 34298556)
24. Alexopoulos GS. The vascular depression hypothesis: 10 years later. Biol Psychiatry 2006;60:1304-5.
25. Krishnan KR, Taylor WD, McQuoid DR, et al. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry 2004;55:390-7.
26. Hackett ML, Yapa C, Parag V, et al. Frequency of depression after stroke: a systematic review of observational studies. Stroke 2005;36:1330-40